NCT02927288View on ClinicalTrials.gov

Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Post-Traumatic Stress DisordersBrain Injuries
Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

United States Army Research Institute of Environmental Medicine

FED

lead

Brigham and Women's Hospital

OTHER

NCT02927288 - Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy | Biotech Hunter | Biotech Hunter